Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial
Journal of Urology | May 5, 2024 | Volume: 212 | Issue: 1 | Pages: 74-86
10.1097/ju.0000000000004020
| PMID 38704840